Anti-Doping Protocols: Medication Rules and the Level Playing Field

Medication rules in British racing serve dual purposes: ensuring a level playing field and protecting horse welfare. Racehorses are elite athletes that may require treatment for injury or illness. Appropriate medication is permitted within strict rules, but race-day medication that could affect performance is prohibited.

The BHA operates the Central Racing Systems (CRS) facility where controlled studies test medication effects and establish detection methods. Horses at CRS receive first-class care and participate in limited studies under Home Office and veterinary control. After 2-3 years, CRS horses are rehomed to continue third careers.

The CRS is a signatory of the Concordat on Openness on Animal Research, committing to transparency about animal use in research. This openness is essential for public trust, racing’s medication research uses live horses, and that use must be justified, controlled, and communicated honestly.

Testing protocols include pre-race sampling, post-race sampling of placed horses and random selections, and out-of-competition testing at training yards. Samples are analysed at BHA-accredited laboratories using internationally standardised methods.

Penalties for medication violations range from fines and training restrictions for minor infractions to multi-year bans for serious doping offences. The BHA publishes all disciplinary outcomes, maintaining transparency in enforcement.